Claudio Bravo

686 total citations
32 papers, 482 citations indexed

About

Claudio Bravo is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, Claudio Bravo has authored 32 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Biomedical Engineering. Recurrent topics in Claudio Bravo's work include Cardiac Structural Anomalies and Repair (9 papers), Mechanical Circulatory Support Devices (9 papers) and Cardiac Arrest and Resuscitation (4 papers). Claudio Bravo is often cited by papers focused on Cardiac Structural Anomalies and Repair (9 papers), Mechanical Circulatory Support Devices (9 papers) and Cardiac Arrest and Resuscitation (4 papers). Claudio Bravo collaborates with scholars based in United States, Chile and Argentina. Claudio Bravo's co-authors include Cristián Lizama, Héctor D. Mansilla, Juanita Freer, Dorothy E. Vatner, Stephen F. Vatner, Marta I. Litter, Javier Fernández, Wilson F. Jardim, Lin Yan and Yoshihiro Ishikawa and has published in prestigious journals such as Circulation, Stroke and Applied Catalysis B: Environmental.

In The Last Decade

Claudio Bravo

29 papers receiving 467 citations

Peers

Claudio Bravo
Claudio Bravo
Citations per year, relative to Claudio Bravo Claudio Bravo (= 1×) peers Zhenhan Li

Countries citing papers authored by Claudio Bravo

Since Specialization
Citations

This map shows the geographic impact of Claudio Bravo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Bravo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Bravo more than expected).

Fields of papers citing papers by Claudio Bravo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Bravo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Bravo. The network helps show where Claudio Bravo may publish in the future.

Co-authorship network of co-authors of Claudio Bravo

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Bravo. A scholar is included among the top collaborators of Claudio Bravo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Bravo. Claudio Bravo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Lu, Olivier Boucherat, Karthik Suresh, et al.. (2024). Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension. Circulation Heart Failure. 17(11). e012067–e012067. 2 indexed citations
2.
Bravo, Claudio, Jee‐Young Moon, Robert C. Kaplan, et al.. (2024). Association of HIV and HCV Infection With Carotid Artery Plaque Echomorphology in the MACS/WIHS Combined Cohort Study. Stroke. 55(3). 651–659. 2 indexed citations
3.
Braghieri, Lorenzo, Antonio Olivas‐Martínez, Aris Karatasakis, et al.. (2024). The Impact of the 2018 Allocation System Change on Patients Bridged With Durable Left Ventricular Assist Device: An Updated UNOS Registry Analysis. ASAIO Journal. 70(5). 456–459. 3 indexed citations
4.
Berardi, Cecilia, Claudio Bravo, Song Li, et al.. (2022). The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support. Journal of Clinical Medicine. 11(7). 2022–2022. 15 indexed citations
5.
Dimarakis, Ioannis, Maziar Khorsandi, Jay D. Pal, et al.. (2022). Pathophysiology and management of valvular disease in patients with destination left ventricular assist devices. Frontiers in Cardiovascular Medicine. 9. 1029825–1029825. 3 indexed citations
6.
Zhang, Kevin, et al.. (2022). Explainable Machine Learning Analysis of Right Heart Failure After Left Ventricular Assist Device Implantation. ASAIO Journal. 69(5). 417–423. 5 indexed citations
7.
Bravo, Claudio, et al.. (2022). Right heart failure after left ventricular assist device: From mechanisms to treatments. Frontiers in Cardiovascular Medicine. 9. 1023549–1023549. 23 indexed citations
8.
Bravo, Claudio, J. Fried, Joshua Z. Willey, et al.. (2021). Presence of Intracardiac Thrombus at the Time of Left Ventricular Assist Device Implantation Is Associated With an Increased Risk of Stroke and Death. Journal of Cardiac Failure. 27(12). 1367–1373. 2 indexed citations
9.
Hameed, Irbaz, N. U. Farrukh Hameed, Ivancarmine Gambardella, et al.. (2021). Systematic Assessment of Online Health Information for Coronary Revascularization. JAMA Internal Medicine. 181(7). 1003–1006. 5 indexed citations
10.
Yamada, Takayuki, Hiroki Ueyama, Nitin Chopra, et al.. (2020). Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure. Kidney International Reports. 5(9). 1486–1494. 14 indexed citations
11.
Villela, Miguel Alvarez, Claudio Bravo, Mahek Shah, et al.. (2020). Prediction of Outcomes after Heart Transplantation Using Machine Learning Techniques. The Journal of Heart and Lung Transplantation. 39(4). S295–S296. 8 indexed citations
12.
Bravo, Claudio, Michael Weinreich, Pedro Villablanca, et al.. (2018). Meta-Analysis and Trial Sequential Analysis Comparing Percutaneous Ventricular Assist Devices Versus Intra-Aortic Balloon Pump During High-Risk Percutaneous Coronary Intervention or Cardiogenic Shock. The American Journal of Cardiology. 122(8). 1330–1338. 37 indexed citations
13.
Bravo, Claudio, et al.. (2018). Torus palatinus. Actas Dermo-Sifiliográficas. 110(1). e6–e6.
14.
Zhang, Jie, Daniel Levy, Marko Oydanich, et al.. (2018). A novel adenylyl cyclase type 5 inhibitor that reduces myocardial infarct size even when administered after coronary artery reperfusion. Journal of Molecular and Cellular Cardiology. 121. 13–15. 11 indexed citations
15.
Kataria, Rachna, et al.. (2017). Dual-antiplatelet Therapy Guidelines and Implications for Perioperative Management. Journal of Cardiothoracic and Vascular Anesthesia. 32(2). 1072–1080. 3 indexed citations
16.
Bravo, Claudio, et al.. (2016). A Food and Drug Administration–Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion. Journal of Pharmacology and Experimental Therapeutics. 357(2). 331–336. 15 indexed citations
17.
Bravo, Claudio, Raymond K. Kudej, Chujun Yuan, et al.. (2012). Metabolomic analysis of two different models of delayed preconditioning. Journal of Molecular and Cellular Cardiology. 55. 19–26. 9 indexed citations
18.
Ho, David, Masanari Umemura, Claudio Bravo, & Kousaku Iwatsubo. (2012). Recent Advance in Isoform-Specific Regulation of Adenylyl Cyclase. Current Enzyme Inhibition. 8(2). 170–182. 1 indexed citations
19.
Lizama, Cristián, et al.. (2005). Photocatalytic Degradation of Surfactants With Immobilized TIO2: Comparing Two Reaction Systems. Environmental Technology. 26(8). 909–914. 18 indexed citations
20.
Pérez, Montserrat, Francesc Torrades, José Peral, et al.. (2001). Multivariate approach to photocatalytic degradation of a cellulose bleaching effluent. Applied Catalysis B: Environmental. 33(2). 89–96. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026